Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class ITerminatedOct 7, 2015Prolotherapy with PhenolNon-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.Hartley Medical Center Pharmacy, Incorporated · D-1830-2015Class ITerminatedOct 7, 2015Prolotherapy with PhenolNon-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.Hartley Medical Center Pharmacy, Incorporated · D-1829-2015Class IIITerminatedOct 7, 2015Rodan & Fields Proactiv SolutionSubpotent Drug: Salicylic acid is subpotent.Guthy-Renker LLC · D-0005-2016Class IIITerminatedOct 7, 2015Rodan & Fields Proactiv SolutionSubpotent Drug: Salicylic acid is subpotent.Guthy-Renker LLC · D-0004-2016Class IIITerminatedOct 7, 2015Rodan & Fields Proactiv SolutionSubpotent Drug: Salicylic acid is subpotent.Guthy-Renker LLC · D-0003-2016Class IIITerminatedOct 7, 2015Rodan & Fields Proactiv SolutionSubpotent Drug: Salicylic acid is subpotent.Guthy-Renker LLC · D-0002-2016Class IIITerminatedOct 7, 2015Rodan & Fields Proactiv SolutionSubpotent Drug: Salicylic acid is subpotent.Guthy-Renker LLC · D-0001-2016Class ITerminatedSep 30, 2015PHENYLephrine HClPresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1828-2015Class ITerminatedSep 30, 2015PHENYLephrine HClPresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1827-2015Class ITerminatedSep 30, 2015PHENYLephrine HClPresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1826-2015Class ITerminatedSep 30, 2015Fentanyl CitratePresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1825-2015Class ITerminatedSep 30, 2015Morphine SulfatePresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1824-2015Class ITerminatedSep 30, 2015Bupivacaine HCl 0.0625%Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1823-2015Class ITerminatedSep 30, 2015PHENYLephrine HClPresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1822-2015Class ITerminatedSep 30, 2015PHENYLephrine HClPresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1821-2015Class IITerminatedSep 30, 2015BLEPHAMIDEPresence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing...Allergan Sales, LLC · D-1820-2015Class IITerminatedSep 30, 2015FML (fluorometholone ophthalmic ointment) 0.1%Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing...Allergan Sales, LLC · D-1819-2015Class IITerminatedSep 30, 2015Refresh P.MPresence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing...Allergan Sales, LLC · D-1818-2015Class IITerminatedSep 30, 2015Refresh Lacri-LubePresence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing...Allergan Sales, LLC · D-1817-2015Class IITerminatedSep 30, 20150.9% Sodium Chloride InjectionLack of Assurance of Sterility: Recalling firm reported a complaint for mold on the interior surface of the overpouch.Baxter Healthcare Corporation · D-1816-2015Class IIOngoingSep 30, 20151% Lidocaine HCl InjectionPresence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.Hospira, Inc. · D-1815-2015Class IITerminatedSep 23, 2015Cevimeline Hydrochloride CapsulesFailed Stability Specifications: product may not meet specification limit for assay test.Apotex Inc. · D-1814-2015Class IIITerminatedSep 23, 2015ClomiPHENE CITRATE TabletsChemical Contamination: impurity failure due to chemical contamination of the active ingredient.EMD Serono, Inc. · D-1813-2015Class IITerminatedSep 23, 2015Tri-Mix T-50/PGE 2/LIDO 2 0.09/0.32/0.04 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1812-2015Class IITerminatedSep 23, 2015Tri-Mix T-50/PGE 2/LIDO 2 0.03/0.18/0.09 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1811-2015Class IITerminatedSep 23, 2015Tri-Mix T-50/PGE 1 0.14/0.08 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1810-2015Class IITerminatedSep 23, 2015Tri-Mix T-50 8.8 mg/0.29 mg/2.9 mcg InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1809-2015Class IITerminatedSep 23, 2015Tri-Mix T-106/PGE 2 0.1/0.14 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1808-2015Class IITerminatedSep 23, 2015Tri-Mix T-106Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1807-2015Class IITerminatedSep 23, 2015Tri-Mix T-105Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1806-2015Class IITerminatedSep 23, 2015Tri-Mix T-102/PGE 2/LIDO 2 0.06/0.3/0.2 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1805-2015Class IITerminatedSep 23, 2015Tri-Mix T-102Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1804-2015Class IITerminatedSep 23, 2015Tri-Mix T-101Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1803-2015Class IITerminatedSep 23, 2015Tri-Mix SUPERLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1802-2015Class IITerminatedSep 23, 2015Tri-Mix ST9ELack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1801-2015Class IITerminatedSep 23, 2015Tri-Mix ST9CLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1800-2015Class IITerminatedSep 23, 2015Tri-Mix ST9ALack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1799-2015Class IITerminatedSep 23, 2015Tri-Mix ST9ALack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1798-2015Class IITerminatedSep 23, 2015Tri-Mix ST4/PGE 2/LIDO 2 0.1/0.05/0.05 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1797-2015Class IITerminatedSep 23, 2015Tri-Mix ST4Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1796-2015

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.